The CorDx Tyfast COVID-19 Ag Rapid Test is now FDA-cleared for prescription use.
CorDx is proud to announce FDA 510(k) clearance of the CorDx Tyfast COVID-19 Ag Rapid Test Rx. Designed for use by healthcare professionals at the point of care, the CorDx Tyfast delivers rapid, qualitative detection of SARS-CoV-2 — no lab required.
From July 1st – 31st, purchase your tests for 21% off.
Contact your CorDx sales rep for pricing information.
CorDx © 2026. All rights reserved.
Privacy Policy. Terms & Conditions.
CorDx delivers POC diagnostics designed to support fast-moving healthcare environments and multi-site operations. No matter how demand fluctuates, CorDx can reliably supply your facility with the tests you need.
Depending on seasonal demand, CorDx can scale up or down to meet demand, meaning you have tests when your patients need them the most. Our team knows it’s never too early to plan for peak season.
From pilot testing to network-wide rollout, CorDx can reliably meet your testing needs. Our robust supply chain and manufacturing capabilities ensure tests arrive at every site in your network, making clinical testing standardization simple.
When you choose CorDx, you get a reliable supply and a diagnostics partner that lets your clinical and operations teams focus on what matters most – providing high-quality, efficient care for patients.
The CorDx Tyfast is a visually read lateral flow immunoassay detecting SARS-CoV-2 nucleocapsid protein antigen from anterior nasal swab specimens. No instrument required.
The CorDx Tyfast COVID-19 Ag Rapid Test Rx is available soon. Stock your practice with fast, FDA-cleared COVID-19 antigen testing.